Araştırma Makalesi

Effect of geraniol and vitamin C on diethylnitrosamine induced experimental hepatocellular carcinogenesis

Cilt: 47 Sayı: 2 30 Haziran 2022
PDF İndir
TR EN

Effect of geraniol and vitamin C on diethylnitrosamine induced experimental hepatocellular carcinogenesis

Abstract

Purpose: This study aimed to investigate the protective effect of geraniol and vitamin C on the experimental hepatocellular carcinogenesis (HCC) model by inducing FL83B hepatocyte cell lines with diethylnitrosamine (DENA). Materials and Methods: The cells prepared in the medium were incubated with DENA (5 μM), geraniol (5 μM), and vitamin C (50 μM) for 48 hours in an incubator at 37 °C and 5% CO2. Groups were designed as follows: Group 1 (Control), group 2 (DENA Control), group 3 (DENA+Geraniol), group 4 (DENA+Vitamin C), and group 5 (DENA+Geraniol+Vitamin C) on standard cell culture plates. Six plates from each experimental group were studied. After the homogenization was centrifuged, analyses of pathway mediators NF-ĸB, AIF, caspase-3, BCL-2, bax, gadd153, GRP78, and COX were performed by the Elisa method. Results: The expression of Bax, caspase-3, COX-2, NFkB, GADD153, AIF, and GRP78 increased in cancer cells when compared to group 1 and decreased in other groups where antiproliferative agents were applied. Bcl-2 expression is decreased when compared to group 1, and expression is increased in other groups where antiproliferative agents are applied. Conclusion: There was a significant hepatoprotective effect in the groups administered geraniol+vitamin C on pathway mediators in a DENA-induced HCC model.

Keywords

Cancer , cell culture , hepatocytes , liver , mediators , pathway

Kaynakça

  1. Kurma K, Manches O, Chuffart F, Sturm N, Gharzeddine K, Zhang J, et al. DEN-induced rat model reproduces key features of human hepatocellular carcinoma. Cancers. 2021;13(19):1–15. DOI: 10.3390/cancers13194981.
  2. Song J, Ding W, Liu B, Liu D, Xia Z, Zhang L, et al. Anticancer effect of caudatin in diethylnitrosamine-induced hepatocarcinogenesis in rats. Molecular Medicine Reports. 2020;22(2):697–706. DOI: 10.3892/mmr.2020.11135.
  3. Karakurt E, Dağ S. Hepatoprotective effect of silymarin against diethylnitrosamine induced oxidative-nitrosative stress in rats. Van Veterinary Journal. 2020;31(2):105–10. DOI: 10.36483/vanvetj.680365.
  4. You Y, Zhu F, Li Z, Zhang LF, Xie Y, Chinnathambi A, et al. Phyllanthin prevents diethylnitrosamine (DEN) induced liver carcinogenesis in rats and induces apoptotic cell death in HepG2 cells. Biomedicine and Pharmacotherapy. 2021;137(January):111335. DOI: 10.1016/j.biopha.2021.111335.
  5. Liu K, Chen J, McCaughan GW. Animal models for hepatocellular carcinoma arising from alcoholic and metabolic liver diseases. Hepatoma Research. 2020;2020. DOI: 10.20517/2394-5079.2019.39.
  6. Zhi H, Cui J, Yang H, Zhang Y, Zhu M. Research progress of geraniol in tumor therapy. Proceedings of Anticancer Research. 2021;5(1):2–6. DOI: 10.26689/par.v5i1.1882.
  7. el Azab EF, Elguindy NM, Yacout GA, Elgamal DA. Hepatoprotective impact of geraniol against ccl4-induced liver fibrosis in rats. Pakistan Journal of Biological Sciences. 2020;23(12):1650–8. DOI. 10.3923/pjbs.2020.1650.1658.
  8. Mohammed MJ, Tadros MG, Michel HE. Geraniol protects against cyclophosphamide-induced hepatotoxicity in rats: Possible role of MAPK and PPAR-γ signaling pathways. Food and Chemical Toxicology. 2020;139. DOI: 10.1016/j.fct.2020.111251.
  9. Blowman K, Magalhães M, Lemos MFL, Cabral C, Pires IM. Anticancer properties of essential oils and other natural products. Evidence-based Complementary and Alternative Medicine. 2018;(3149362):1–12. DOI: 10.1155/2018/3149362.
  10. Queiroz TB, Santos GF, Ventura SC, Hiruma-Lima CA, Gaivão IOM, Maistro EL. Cytotoxic and genotoxic potential of geraniol in peripheral blood mononuclear cells and human hepatoma cell line (HepG2). Genetics and Molecular Research. 2017;16(3). DOI: 10.4238/gmr16039777.

Kaynak Göster

MLA
Taşkın Şenol, Gamze, vd. “Effect of geraniol and vitamin C on diethylnitrosamine induced experimental hepatocellular carcinogenesis”. Cukurova Medical Journal, c. 47, sy 2, Haziran 2022, ss. 738-46, doi:10.17826/cumj.1091707.